Emad Ibrahim, MD, Inc is a clinical research site located in Redlands, California, United States 92373.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Emad Ibrahim, MD, Inc has participated in 5 clinical trials with 2 currently active.
Therapeutic areas: Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.
Sponsors: Takeda, Shanghai Henlius Biotech, Nektar Therapeutics.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Emad Ibrahim, MD, Inc has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Emad Ibrahim, MD, Inc has 5 clinical trials on record, with 2 currently active. Their work covers Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute.
Yes — Emad Ibrahim, MD, Inc holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.